| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |